Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
Open Access
- 17 August 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1208977
Abstract
Background: The expression of serine protease granzyme-B (GzmB) by circulating CD8+ T lymphocytes has been recently suggested as a biomarker for poor immunotherapy response and severe disability in patients with Neuromyelitis Optica spectrum disorders (NMOSD). In parallel, venous thromboembolism (VTE) has been reported mainly in NMOSD patients exhibiting transverse myelitis.Case presentation: Here, we describe an Aquaporin-4 positive (AQP4-positive) NMOSD patient who showed short myelitis (SM) and experienced a fatal pulmonary thromboembolism/lower extremity deep vein thrombosis during anti-CD20 treatment. Flow cytometry analyses from the peripheral blood revealed an enhanced cytotoxic behavior through circulating CD8+GzmB+ T, CD4+GzmB+ T lymphocytes, and residual CD19+GzmB+ B cells.Conclusions: Fatal VTE may be a rare outcome, particularly in patients exhibiting SM, and may share poorly understood immunological mechanisms with AQP4-positive NMOSD severity.Keywords
This publication has 35 references indexed in Scilit:
- Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitisActa Neuropathologica, 2016
- Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawalMultiple Sclerosis Journal, 2016
- Involvement of CD8+ T Cells in Multiple SclerosisFrontiers in Immunology, 2015
- The Overlapping Roles of Antimicrobial Peptides and Complement in Recruitment and Activation of Tumor-Associated Inflammatory CellsFrontiers in Immunology, 2015
- B cells in MS and NMO: pathogenesis and therapySeminars in Immunopathology, 2014
- Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivoAnnals of Neurology, 2009
- Preferential recruitment of interferon‐γ–expressing TH17 cells in multiple sclerosisAnnals of Neurology, 2009
- Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammationNature Medicine, 2007
- Phenotypic characterization of autoreactive T cells in multiple sclerosisJournal of Neuroimmunology, 2006
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004